AIM market continues recovery
RNS Hotlist with Zak Mir: STX, INSG, HAMA, SEI, FRES, HEX, EME, IGG, RCP, KLR & SNX
Shield Therapeutics plc (STX), a commercial stage pharmaceutical company specialising in iron deficiency, announced the filing, and acceptance by the Chinese National Medical Products Administration (‘NMPA’), of a Marketing Authorisation
RNS Hotlist with Zak Mir: VLRM, SRVL, REE, CHLL, JAN, CDL, SWC, STX, FMET, NEWS & ATN
Valereum Plc (AQSE: VLRM), a company aiming to be the global market leader in the rapidly developing tokenised digital markets sector, announced that it has signed a Memorandum of Understanding with
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 29th January 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 24th November 2025
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
RNS Hotlist with Zak Mir: FPP, ITM, STX, MWE, ORCP, EST, KAV, HE1, AREC, FMET & MKA
The Telegraph yesterday proved it does not have a clue regarding what it is doing on financial matters: Key moments from yesterday. The FTSE 100 is up 1% so far pre-market.
Share Talk Weekly Small Cap Movers & Shakers, Saturday 8th March 2025
The FTSE 100 struggled to regain ground on Friday after a turbulent week of losses amid Tariff Uncertainty. London’s blue-chip index edged down three points to 8,680, ending the day
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 21st November 2024
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Avacta Group,
Share Talk Weekly Small Cap Movers & Shakers, Saturday 10th August 2024
Global stock exchanges have experienced a roller coaster ride as fears of a US recession triggered a global sell-off, which has gradually been reversed. The AIM All-Share declined by 0.6%
Shield Therapeutics (AIM:STX) shares soar 47% as commercial momentum accelerates
Shield Therapeutics PLC (AIM: STX, OTCQX: SHIEF) shares surged 47% following the release of impressive second-quarter trading results.
RNS Hotlist with Zak Mir: STX, CSSG, POW, TOM, FDBK, EPP & ONDO
Shield Therapeutics (STX), a commercial-stage pharmaceutical company, announced topline results for Q4 2023 and provides an unaudited trading update for the year ended 31 December 2023.
Share Talk Weekly Small Cap Movers & Shakers, Saturday 30th September 2023
The British growth markets in 2023 have largely been plagued by a lack of funding.